Anti-AARSD1 antibody

Anti-AARSD1 antibody

Cat.#: 104524

Special Price 145.0 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Anti-AARSD1 antibody
  • Documents
  • Description
    Rabbit polyclonal to AARSD1
  • Tested applications
    ELISA, WB, IP
  • Species reactivity
    Human AARSD1
  • Alternative names
    alanyl-tRNA synthetase domain containing 1 antibody; Aarsd1 antibody; 1110069E20Rik antibody; 2310044P18Rik antibody; AA589600 antibody; AlaX antibody; AlaXp-II antibody; alanyl-tRNA deacylase alaX antibody; alanyl-tRNA editing protein Aarsd1 antibody; alanyl-tRNA synthetase domain-containing protein 1 antibody
  • Isotype
    Rabbit IgG
  • Preparation
    Produced in rabbits immunized with purified, recombinant Human AARSD1 (rh AARSD1; Q9BTE6-2; Thr176-Glu525). AARSD1 specific IgG was purified by Human AARSD1 affinity chromatography.
  • Clonality
    Polyclonal
  • Formulation
    0.2 μm filtered solution in PBS
  • Storage instructions
    This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free.
    Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.
  • Applications

    WB: 2-10 μg/mL

    ELISA: 0.1-0.2 μg/mL

    This antibody can be used at 0.1-0.2 μg/mL with the appropriate secondary reagents to detect Human AARSD1. The detection limit for Human AARSD1 is < 0.039 ng/well.

    IP: 1-4 μg/mg of lysate

  • Background
    AARSD1 belongs to the class-II aminoacyl-tRNA synthetase family, Alax-L subfamily. AARSD1 binds 1 zinc ion per subunit functions in trans to edit the amino acid moiety from incorrectly charged tRNA(Ala). Four transcript variants have been described for AARSD1: NM_025267.3, NM_001136042.2, NM_001142653.1 and NM_001142654.1. It has been determined that the latter two variants represent a distinct upstream locus, which is now represented by GeneID:100885848 (PTGES3L), while the former two variants represent readthrough transcripts between PTGES3L and this locus (AARSD1). The readthrough locus (PTGES3L-AARSD1) is now represented by GeneID:100885850.
  • References
    • Tatham MH, et al. (2011) Comparative proteomic analysis identifies a role for SUMO in protein quality control. Oncogene. 19(17):2120-8.
    • Kim W, et al. (2011) Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 44(2):325-40.
    • Udeshi ND, et al. (2012) Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition. Mol Cell Proteomics. 11(5):148-59.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"